RegenLab USA, international biotech co, joins Brooklyn Army Terminal’s BioBAT, celebrates with ribbon-cutting ceremony
RegenLab USA, the American affiliate of a Swiss-based company that leads in medical biotechnologies and specializes in cellular therapies, officially joined the BioBAT life science incubator at the Brooklyn Army Terminal with a ribbon-cutting ceremony on Monday, Nov. 8.
The event — which included local leaders such as Brooklyn Chamber of Commerce President and CEO Randy Peers; Susan Rosenthal, senior vice president of life sciences and health care at the New York City Economic Development Corporation; and Dr. Eva Cramer, president of BioBAT and vice president of biotechnology and scientific affairs at SUNY Downstate Medical Center — welcomed RegenLab USA’s CEO Antoine Turzi to the massive and historic Sunset Park space.
“This company specializes in cutting-edge cellular therapy and tissues engineering medical devices,” Peers said. “Between operations research design and manufacturing, [RegenLab USA] is going to ultimately produce 150 jobs here and pay an average of $110,000 a year. This is an investment directly here in Brooklyn.”